Related Experiment Video
Updated: Jul 29, 2026

Transthoracic Speckle Tracking Echocardiography for the Quantitative Assessment of Left Ventricular Myocardial Deformation
Published on: October 20, 2016
Left ventricular twist in hypertrophic cardiomyopathy : Predictor of nonsustained ventricular tachycardia
O Candan1, C Gecmen2, A Kalaycı2
1Cardiology Clinic, Kartal Kosuyolu Heart Training and Research Hospital, 34846, Kartal, İstanbul, Turkey. oz_candan@hotmail.com.
Insights
In hypertrophic cardiomyopathy (HCM) patients, decreased global longitudinal peak strain (GLPS) and increased twist are key predictors of nonsustained ventricular tachycardia (NsVT). Speckle-tracking echocardiography (STE) parameters can help identify at-risk individuals.
Area of Science:
- Cardiology
- Medical Imaging
- Arrhythmology
Background:
- Hypertrophic cardiomyopathy (HCM) is a significant cause of sudden cardiac death.
- Nonsustained ventricular tachycardia (NsVT) is a common complication in HCM patients.
- Predicting NsVT risk is crucial for timely intervention and improved patient outcomes.
Purpose of the Study:
- To evaluate the predictive value of clinical and echocardiographic parameters for NsVT in HCM.
- To assess the role of speckle-tracking echocardiography (STE) in identifying NsVT risk.
- To determine specific echocardiographic markers associated with NsVT occurrence.
Main Methods:
- A cohort of 59 HCM patients underwent clinical assessment, ECG, and echocardiography (2D and STE).
- Holter monitoring was performed within 24-72 hours to detect NsVT.
- Patients were grouped based on the presence or absence of NsVT.
Main Results:
- NsVT was detected in 29% of patients.
- Higher twist and apical rotation, along with decreased global longitudinal peak strain (GLPS), were observed in patients with NsVT.
- Multivariate analysis identified GLPS (OR: 1.406) and twist (OR: 1.236) as independent predictors of NsVT.
Conclusions:
- Decreased GLPS and increased twist are significant predictors of NsVT in HCM.
- Easily measurable STE parameters can aid in identifying HCM patients at higher risk for arrhythmia.
- These findings support the use of STE for risk stratification in HCM management.
Background:
We investigated the efficacy of clinical and classic echocardiographic parameters in predicting the occurrence of nonsustained ventricular tachycardia (NsVT) in patients with hypertrophic cardiomyopathy (HCM).
Methods:
The study comprised 59 patients with HCM (47 male, [80%]; mean age, 48.48 ± 14.16 years). Clinical, electrocardiographic, as well as classic two-dimensional and speckle-tracking echocardiography (STE) data were collected. All patients had Holter monitoring within 24-72 h of the echocardiographic examination. NsVT was defined as three or more consecutive premature wide QRS complexes with a heart rate of > 100 bpm. The patient population was categorized into groups based on the occurrence or absence of NsVT on the 24-h Holter recordings.
Results:
NsVT was observed in 17 patients (29%). In these patients, higher twist (14.4 ± 3.8 vs.18 ± 7.9; p = 0.02), higher apical rotation (8.7 ± 4.2 vs. 12.2 ± 7; p = 0.02), higher sudden cardiac death risk score (4.4 ± 2.2 vs. 7 ± 3.3; p = 0.007), and decreased global longitudinal peak strain (GLPS; -12.8 ± 3.1 vs. -10.6 ± 2.8; p = 0.014) were observed. In the multivariate logistic regression analysis, including GLPS and twist, GLPS (Odds Ratio [OR]: 1.406; 95% CI: 1.087-1.818; p = 0.009) and twist (OR: 1.236; 95% CI: 1.056-1.446; p = 0.008) were found to be independent predictors of NsVT. In the receiver operating characteristic curve analysis, GLPS < -11.9% predicted NsVT with 82% sensitivity and 60% specificity (area under the curve [AUC]: 0.70; p = 0.014) and twist > 15.2° predicted NsVT with 70% sensitivity and 58% specificity (AUC: 0.69; p = 0.027).
Conclusion:
Decreased GLPS and increased twist were predictive of NsVT in HCM patients. Parameters that can easily be measured with STE can help detect patients who may develop arrhythmia.
Related Concept Videos
Dysrhythmias III: Characteristics of Dysrhythmias
Heart Failure II: Pathophysiology
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy

